Literature DB >> 25493162

Recurrent implantation failure is more frequently seen in female patients with poor prognosis.

Pelin Ocal1, Tayfur Cift2, Berk Bulut1, Eray Balcan1, Ismail Cepni1, Begum Aydogan1, Tulay Irez1.   

Abstract

BACKGROUND: This study evaluated the characteristics and results of patients who suffer from recurrent implantation failure (RIF).
MATERIALS AND METHODS: In this cross sectional study, a total of 2183 cases who were evaluated retrospectively at the Istanbul University Cerrahpasa Medical Faculty, Department of Obstetrics and Gyneacology, IVF unit between 2000-2007. According to the data gathered, we included 1822 cases in this study. We compared 185 patients with RIF to 1637 women without RIF.
RESULTS: Pregnancy was achieved by 589 couples out of 1822 (32%). The implantation rate was 10%, which declined to 5.8% after the fourth attempt. In the RIF group, patients' mean age was higher and there were more overweight women, the duration of fertility was longer, day 3 follicle stimulation hormone (FSH) levels and the total gonadotropin dose administered were higher, mean level of Estradiol (E2) on the human chorionic gonadotropin (hCG) day was lower, and the mean level of progesterone on the hCG day was elevated compared to the non-RIF group. Although the comparison of MII oocyte number was not significant, the mean number of fertilized oocytes was found to be significant in favor of the non-RIF group. The endometrial thicknesses were found to be similar for both groups. Comparison of sperm motility and morphology were statistically significant in favor of the RIF group.
CONCLUSION: In our study, we have found that the group with RIF were comprised of patients with poor prognosis who were older, overweight, had a longer infertility duration, a higher FSH level, and needed more gonadotropin doses in controlled ovarian hyperstimulation (COH). Sperm motility and morphology were better in the RIF group compared to the non-RIF group, and multiple pregnancy rates were lower in RIF patients.

Entities:  

Keywords:  Implantation; In Vitro Fertilization; Recurrent Implantation Failure

Year:  2012        PMID: 25493162      PMCID: PMC4258244     

Source DB:  PubMed          Journal:  Int J Fertil Steril        ISSN: 2008-0778


  29 in total

1.  The role of genetic factors in age at natural menopause.

Authors:  J P de Bruin; H Bovenhuis; P A van Noord; P L Pearson; J A van Arendonk; E R te Velde; W W Kuurman; M Dorland
Journal:  Hum Reprod       Date:  2001-09       Impact factor: 6.918

Review 2.  Towards better quality research in recurrent implantation failure: standardizing its definition is the first step.

Authors:  Tarek El-Toukhy; Mohamed Taranissi
Journal:  Reprod Biomed Online       Date:  2006-03       Impact factor: 3.828

Review 3.  Investigation and treatment of repeated implantation failure following IVF-ET.

Authors:  E J Margalioth; A Ben-Chetrit; M Gal; T Eldar-Geva
Journal:  Hum Reprod       Date:  2006-08-12       Impact factor: 6.918

4.  Ovarian reserve tests for predicting fertility outcomes for assisted reproductive technology: the International Systematic Collaboration of Ovarian Reserve Evaluation protocol for a systematic review of ovarian reserve test accuracy.

Authors:  N P Johnson; E M Bagrie; A Coomarasamy; S Bhattacharya; A N Shelling; S Jessop; C Farquhar; K S Khan
Journal:  BJOG       Date:  2006-12       Impact factor: 6.531

Review 5.  A systematic review of tests predicting ovarian reserve and IVF outcome.

Authors:  F J Broekmans; J Kwee; D J Hendriks; B W Mol; C B Lambalk
Journal:  Hum Reprod Update       Date:  2006-08-04       Impact factor: 15.610

6.  A randomized, double-blind, multicenter study comparing a starting dose of 100 IU or 200 IU of recombinant follicle stimulating hormone (Puregon) in women undergoing controlled ovarian hyperstimulation for IVF treatment.

Authors:  Seang Lin Tan; Timothy J Child; Anthony P Cheung; Margo R Fluker; Albert Yuzpe; Robert Casper; Peter Leung; Kenneth Cadesky; Victoria J Davis
Journal:  J Assist Reprod Genet       Date:  2005-02       Impact factor: 3.412

7.  Assisted reproductive technologies (ART) in Canada: 2007 results from the Canadian ART Register.

Authors:  Joanne Gunby; François Bissonnette; Clifford Librach; Lisa Cowan
Journal:  Fertil Steril       Date:  2010-07-24       Impact factor: 7.329

8.  Cost analysis of singleton versus twin pregnancies after in vitro fertilization.

Authors:  H G Marieke Lukassen; Yvonne Schönbeck; Eddy M M Adang; Didi D M Braat; Gerhard A Zielhuis; Jan A M Kremer
Journal:  Fertil Steril       Date:  2004-05       Impact factor: 7.329

Review 9.  Number of embryos for transfer following in-vitro fertilisation or intra-cytoplasmic sperm injection.

Authors:  Zabeena Pandian; Siladitya Bhattacharya; Ozkan Ozturk; Gamal Serour; Allan Templeton
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

Review 10.  Guidelines for the number of embryos to transfer following in vitro fertilization No. 182, September 2006.

Authors: 
Journal:  Int J Gynaecol Obstet       Date:  2008-08       Impact factor: 3.561

View more
  1 in total

1.  Gonadotropin-releasing hormone agonist downregulation combined with hormone replacement therapy improves the reproductive outcome in frozen-thawed embryo transfer cycles for patients of advanced reproductive age with idiopathic recurrent implantation failure.

Authors:  Juanzi Shi; Hanying Zhou; Dan Pan; Jie Yang; Ni Zhang; Lei Wang; Na Li
Journal:  Reprod Biol Endocrinol       Date:  2022-02-03       Impact factor: 5.211

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.